SQ109, a New Drug Lead for Chagas Disease

We tested the antituberculosis drug SQ109, which is currently in advanced clinical trials for the treatment of drug-susceptible and drug-resistant tuberculosis, for its in vitro activity against the trypanosomatid parasite Trypanosoma cruzi, the causative agent of Chagas disease. SQ109 was found to...

Full description

Bibliographic Details

Published:	2015
Subjects:	antituberculosis drug SQ109 trypanosomatid parasite Chagas disease tuberculosis cell killing
Online Access:	http://hdl.handle.net/10872/15711
Tags:	Add Tag No Tags, Be the first to tag this record!